Skip to content

uniQure QURE Market capitalization

Market capitalization at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$2.06B-39.4%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$3.04B+54.2%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$5.64B+40.3%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$4.57B+56.4%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$7.55B+45.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$14.4B+119%

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Computed from the period-end share price: $1.02B.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's market capitalization?
uniQure (QURE) reported market capitalization of $1.02B in Q1 2026.
How has uniQure's market capitalization changed year-over-year?
uniQure's market capitalization increased by 78.4% year-over-year, from $573.21M to $1.02B.
What is the long-term trend for uniQure's market capitalization?
Over 5 years (2020 to 2025), uniQure's market capitalization has grown at a -2.2% compound annual growth rate (CAGR), from $1.67B to $1.49B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.